PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

TalentRooster Video Resume Service Experiences Explosive Growth, Now Hosting Over 4,000 Video Resumes

2010-11-30
TalentRooster (http://www.talentrooster.com), the world's leading video resume service, today announced that it has exceeded 4,000 video resumes in its searchable video resume repository -- more than doubling its database in the past two months. "The technology is virtually exploding," says TalentRooster CEO and President David DeCapua. "Because video resumes are quickly replacing paper resumes as a preferred method of screening candidates, we're seeing employers and recruiting companies jump at the chance to integrate video resumes into their hiring process, increasing ...

Sour research, sweet results

2010-11-25
This Thanksgiving, when you bite into the cranberry sauce and the tartness smacks your tongue as hard as that snide comment from your sister, consider the power of sour. Neurobiology researchers at the University of Southern California have made a surprising discovery about how some cells respond to sour tastes. Of the five taste sensations — sweet, bitter, sour, salty and umami — sour is arguably the strongest yet the least understood. Sour is the sensation evoked by substances that are acidic, such as lemons and pickles. The more acidic the substance, the more sour ...

Deciphering how CD4 T cells die during HIV infection

2010-11-25
SAN FRANCISCO, CA—November 24, 2010—Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection–namely how HIV promotes the death of CD4 T cells. It is the loss of this critical subset of immune cells that leads to the development of AIDS. Most immune cells that die during HIV infection are seemingly not infected, a phenomenon formerly described as "bystander cell killing." Now the Gladstone scientists report that these "bystander" cells are actually the victims of a failed or abortive form of viral infection. Their ...

Breastfeeding while taking seizure drugs may not harm child's IQ

2010-11-25
ST. PAUL, Minn. – There's good news for women with epilepsy. Breastfeeding your baby while taking your seizure medication may have no harmful effect on your child's IQ later on, according to a study published in the November 24, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. "While more research is needed with larger numbers of women and their babies, these results are reassuring to women who want to give their babies all the benefits of breastfeeding but also need to remain on their epilepsy medications to avoid devastating ...

Proton-pump inhibitors and birth defects -- some reassurances, but more needed warns epidemiologist

2010-11-25
(Boston) - Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed. The original study found that on the basis of data from more than 840,000 live births in Denmark, there was no evidence to suggest that the use of the most common PPIs (omeprazole, lansoprazole, and esomeprazole) anytime during pregnancy ...

Study finds that the same face may look male or female

2010-11-25
CAMBRIDGE, Mass. -- Neuroscientists at MIT and Harvard have made the surprising discovery that the brain sees some faces as male when they appear in one area of a person's field of view, but female when they appear in a different location. The findings challenge a longstanding tenet of neuroscience — that how the brain sees an object should not depend on where the object is located relative to the observer, says Arash Afraz, a postdoctoral associate at MIT's McGovern Institute for Brain Research and lead author of a new paper on the work. "It's the kind of thing you ...

A decade of refinements in transplantation improves long-term survival of blood cancers

2010-11-25
SEATTLE – A decade of refinements in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at Fred Hutchinson Cancer Research Center. Among the major findings of the study, which compared transplant-patient outcomes in the mid-'90s with those a decade later: After adjusting for factors known to be associated with outcome, the researchers observed a statistically significant 60 percent reduction in the ...

Study of 10 other hospitals found no reduction in adverse medical events over 6 years

2010-11-25
STANFORD, Calif. — Despite concerted efforts, no decreases in patient harm were detected at 10 randomly selected North Carolina hospitals between 2002 and 2007, according to a new study from the Stanford University School of Medicine, Harvard Medical School and the Institute for Healthcare Improvement. Since a 1999 Institute of Medicine report sounded the alarm about high medical error rates, most U.S. hospitals have changed their operations to keep patients safer. The researchers wanted to assess whether these patient-safety efforts reduced harm. They studied hospitals ...

Pulsating star mystery solved

Pulsating star mystery solved
2010-11-25
The new results, from a team led by Grzegorz Pietrzyński (Universidad de Concepción, Chile, Obserwatorium Astronomiczne Uniwersytetu Warszawskiego, Poland), appear in the 25 November 2010 edition of the journal Nature. Grzegorz Pietrzyński introduces this remarkable result: "By using the HARPS instrument on the 3.6-metre telescope at ESO's La Silla Observatory in Chile, along with other telescopes, we have measured the mass of a Cepheid with an accuracy far greater than any earlier estimates. This new result allows us to immediately see which of the two competing ...

Bonn physicists create a 'super-photon'

Bonn physicists create a super-photon
2010-11-25
By cooling Rubidium atoms deeply and concentrating a sufficient number of them in a compact space, they suddenly become indistinguishable. They behave like a single huge "super particle." Physicists call this a Bose-Einstein condensate. For "light particles," or photons, this should also work. Unfortunately, this idea faces a fundamental problem. When photons are "cooled down," they disappear. Until a few months ago, it seemed impossible to cool light while concentrating it at the same time. The Bonn physicists Jan Klärs, Julian Schmitt, Dr. Frank Vewinger, and Professor ...

Erythromycin A produced in E. coli for first time

2010-11-25
MEDFORD/SOMERVILLE, Mass. -- Researchers at Tufts University School of Engineering have reported the first successful production of the antibiotic erythromycin A, and two variations, using E. coli as the production host. The work, published in the November 24, 2010, issue of Chemistry and Biology, offers a more cost-effective way to make both erythromycin A and new drugs that will combat the growing incidence of antibiotic resistant pathogens. Equally important, the E. coli production platform offers numerous next-generation engineering opportunities for other natural ...

How pathogens hijack host plants

2010-11-25
Palo Alto, CA— Infestation by bacteria and other pathogens result in global crop losses of over $500 billion annually. A research team led by the Carnegie Institution's Department of Plant Biology developed a novel trick for identifying how pathogens hijack plant nutrients to take over the organism. They discovered a novel family of pores that transport sugar out of the plant. Bacteria and fungi hijack the pores to access the plant sugar for food. The first goal of any pathogen is to access the host's food supply to allow them to reproduce in large numbers. This is the ...

UCLA researchers discover drug resistance mechanisms in most common form of melanoma

2010-11-25
Researchers with UCLA's Jonsson Comprehensive Cancer Center have found that melanoma patients whose cancers are caused by mutation of the BRAF gene become resistant to a promising targeted treatment through another genetic mutation or the overexpression of a cell surface protein, both driving survival of the cancer and accounting for relapse. The study, published Nov. 24, 2010, in the early online edition of the peer-reviewed journal Nature, could result in the development of new targeted therapies to fight resistance once the patient stops responding and the cancer ...

Researchers shine light on how some melanoma tumors evade drug treatment

2010-11-25
The past year has brought to light both the promise and the frustration of developing new drugs to treat melanoma, the most deadly form of skin cancer. Early clinical tests of a candidate drug aimed at a crucial cancer-causing gene revealed impressive results in patients whose cancers resisted all currently available treatments. Unfortunately, those effects proved short-lived, as the tumors invariably returned a few months later, able to withstand the same drug to which they first succumbed. Adding to the disappointment, the reasons behind these relapses were unclear. Now, ...

An answer to a longstanding question: How HIV infection kills T cells

2010-11-25
Researchers appear to have an explanation for a longstanding question in HIV biology: how it is that the virus kills so many CD4 T cells, despite the fact that most of them appear to be "bystander" cells that are themselves not productively infected. That loss of CD4 T cells marks the progression from HIV infection to full-blown AIDS, explain the researchers who report their findings in studies of human tonsils and spleens in the November 24th issue of Cell, a Cell Press publication. "In [infected] primary human tonsils and spleens, there is a profound depletion of CD4 ...

Danish researchers finally solve the obesity riddle

Danish researchers finally solve the obesity riddle
2010-11-25
Researchers at the Faculty of Life Sciences (LIFE), University of Copenhagen, can now unveil the results of the world's largest diet study: If you want to lose weight, you should maintain a diet that is high in proteins with more lean meat, low-fat dairy products and beans and fewer finely refined starch calories such as white bread and white rice. With this diet, you can also eat until you are full without counting calories and without gaining weight. Finally, the extensive study concludes that the official dietary recommendations are not sufficient for preventing obesity. ...

Whale sharks do the math to avoid that sinking feeling

2010-11-25
They are the largest fish species in the ocean, but the majestic gliding motion of the whale shark is, scientists argue, an astonishing feat of mathematics and energy conservation. In new research published today in the British Ecological Society's journal Functional Ecology marine scientists reveal how these massive sharks use geometry to enhance their natural negative buoyancy and stay afloat. For most animals movement is crucial for survival, both for finding food and for evading predators. However, movement costs substantial amounts of energy and while this is true ...

Fatal blood clot genetic risk breakthrough announcement

Fatal blood clot genetic risk breakthrough announcement
2010-11-25
An international team led by researchers from the Universities of Leicester and Cambridge has announced a breakthrough in identifying people at risk of developing potentially fatal blood clots that can lead to heart attack. The discovery, published this week (25 November) in the leading haematology journal Blood, is expected to advance ways of detecting and treating coronary heart disease – the most common form of disease affecting the heart and an important cause of premature death. The research led by Professor Alison Goodall from the University of Leicester and Professor ...

Growth-factor gel shows promise as hearing-loss treatment

2010-11-25
A new treatment has been developed for sudden sensorineural hearing loss (SSHL), a condition that causes deafness in 40,000 Americans each year, usually in early middle-age. Researchers writing in the open access journal BMC Medicine describe the positive results of a preliminary trial of insulin-like growth factor 1 (IGF1), applied as a topical gel. Takayuki Nakagawa, from Kyoto University, Japan, worked with a team of researchers to test the gel in 25 patients whose SSHL had not responded to the normal treatment of systemic gluticosteroids. He said, "The results indicated ...

Each 5-degree temperature rise boosts kids' hospital admissions for serious injury by 10 percent

2010-11-25
Every 5°C rise in maximum temperature pushes up the rate of hospital admissions for serious injuries among children, reveals one of the largest studies of its kind published online in Emergency Medicine Journal. Conversely, each 5° C drop in the minimum daily temperature boosts adult admissions for serious injury by more than 3%, while snow prompts an 8% rise, the research shows. The authors base their findings on the patterns of hospital treatment for both adults and children in 21 emergency care units across England, belonging to the Trauma Audit and research Network ...

Workplace asthma costs UK at least $158 million a year

2010-11-25
Workplace asthma costs the UK at least £100 million a year, and may be as high as £135 million, reveals research published online in Thorax. An estimated 3,000 new cases of occupational asthma are diagnosed every year in the UK, but the condition is under diagnosed, say the authors. They reviewed published data on the costs of all asthma and workplace asthma, as well as the impact costs. The evidence was then used to calculate the costs of workplace asthma on an individual's ability to work and their wider life, including their use of health services, based on a ...

Epilepsy drugs may not affect IQ of breastfed babies, study says

2010-11-25
New research from the Emory University School of Medicine offers reassurance for nursing mothers with epilepsy. According to a study published in the November 24 online issue of Neurology, the medical journal of the American Academy of Neurology, breastfeeding a baby while taking a seizure medication may have no harmful effect on the child's IQ later in life. "Our results showed no difference in IQ scores between the children who were breastfed and those who were not," says study author Kimford Meador, MD, professor of neurology, Emory University School of Medicine and ...

Jet-lagged and forgetful? It's no coincidence

2010-11-25
Chronic jet lag alters the brain in ways that cause memory and learning problems long after one's return to a regular 24-hour schedule, according to research by University of California, Berkeley, psychologists. Twice a week for four weeks, the researchers subjected female Syrian hamsters to six-hour time shifts – the equivalent of a New York-to-Paris airplane flight. During the last two weeks of jet lag and a month after recovery from it, the hamsters' performance on learning and memory tasks was measured. As expected, during the jet lag period, the hamsters had trouble ...

Being a 'good sport' can be critical to maintaining lifelong physical activity

2010-11-25
Toronto, ON – November 24 – It's never fun riding the bench – but could it also make you less likely to be physically active in the future? That's one of the questions being explored by Mark Eys, an associate professor of kinesiology and physical education at Wilfrid Laurier University and the Canada Research Chair in Group Dynamics and Physical Activity. Eys is presenting his work as part of this week's Canada Research Chairs conference in Toronto. Eys, who also teaches out of the university's psychology department, is studying group cohesion – which, in sporting ...

Diabetes drug could work against Alzheimer's

2010-11-25
Bonn, 24th November 2010. Metformin, a drug used in type 2-diabetes might have the potential to also act against Alzheimer's disease. This has been shown in a study from scientists of the German Center for Neurodegenerative Diseases (DZNE), the University of Dundee and the Max-Planck-Institute for Molecular Genetics. The researchers have found out that the diabetes drug metformin counteracts alterations of the cell structure protein Tau in mice nerve cells. These alterations are a main cause of the Alzheimer's disease. Moreover, they uncovered the molecular mechanism of ...
Previous
Site 7336 from 7890
Next
[1] ... [7328] [7329] [7330] [7331] [7332] [7333] [7334] [7335] 7336 [7337] [7338] [7339] [7340] [7341] [7342] [7343] [7344] ... [7890]

Press-News.org - Free Press Release Distribution service.